Molecular decoys: ligand-binding recombinant proteins protect mice from curarimimetic neurotoxins.
AUTOR(ES)
Gershoni, J M
RESUMO
Mimic ligand-binding sites of the nicotinic acetylcholine receptor bind d-tubocurarine and alpha-bungarotoxin in vitro. Injection of such binding sites into mice could act as molecular decoys in vivo, providing protection against toxic ligands. This hypothesis of molecular "decoyance" has been tested in greater than 250 mice. Bacterially produced cholinergic binding sites provided a 2-fold increase in the survival rate of animals challenged with curarimimetic neurotoxins. Possible considerations for decoy designs and their applications are discussed.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=280367Documentos Relacionados
- Autoimmune-Like Antibodies to the Ligand-Binding Sites of Myeloma Proteins
- Ligand-binding and heterodimerization activities of a conserved region in the ligand-binding domain of the thyroid hormone receptor.
- A multiple ligand-binding radioimmunoassay of diiodotyrosine.
- The molecular structure of the Toll-like receptor 3 ligand-binding domain
- A streptavidin mutant with altered ligand-binding specificity